TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/08/2022
Back to search
Official data from USPTO
KINOMEVIEW
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
KINOMEVIEW
ST13
US500000085170543Class
1, 42
Filing
85170543
Registration
3976075
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
34
Latest update
03/08/2022
Trademark type
Word
Nice classes
1, 42
Filing date
11/05/2010
Registration date
06/07/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/01/2021
Last transaction
03/08/2022
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/15/2011
First use in commerce
04/15/2011
Drawing code
4
Owner type
03
Owner location
Danvers, MA, US
Examiner
FRYE, KIMBERLY
Law office
M40
Current location
TMO LAW OFFICE 113
Holders and representatives
Holders
Cell Signaling Technology, Inc.
Representatives
Keith A. Weltsch, Esq. Sunstein LLP
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biochemical catalysts; Biochemical reagents used for non-medical purposes; Biochemicalsmonoclonal antibodies for in vitro scientific or research use; Biochemicalspolypeptides for in vitro research use; Reagent for chemical analyses; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis
Class 42
Chemical analysis; Consulting services in the fields of biotechnologypharmaceutical research and development and genetic science; Providing laboratory research services in the field of gene expressioncancer biology
Publications
History of USPTO decisions and trademark events.
34 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/08/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
09/01/2021
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
09/01/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
09/01/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/01/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
05/06/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/07/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/10/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06/20/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06/20/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/14/2017
E815
TEAS SECTION 8 & 15 RECEIVED
04/21/2017
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/07/2016
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/31/2011
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/31/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
06/07/2011
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/03/2011
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
04/30/2011
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/27/2011
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/25/2011
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/25/2011
IUAF
USE AMENDMENT FILED
04/22/2011
EISU
TEAS STATEMENT OF USE RECEIVED
04/22/2011
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/05/2011
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/08/2011
PUBO
PUBLISHED FOR OPPOSITION
02/08/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/04/2011
ALIE
ASSIGNED TO LIE
01/04/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/08/2010
DOCK
ASSIGNED TO EXAMINER
12/08/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/10/2010
NWAP
NEW APPLICATION ENTERED
11/09/2010
Continuous trademark protection
Get notified about every new filing that threatens KINOMEVIEW or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.